X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (425) 425
Patent (56) 56
Publication (54) 54
Conference Proceeding (22) 22
Book / eBook (4) 4
Book Chapter (4) 4
Book Review (2) 2
Dissertation (2) 2
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (180) 180
index medicus (133) 133
cardiac & cardiovascular systems (126) 126
female (114) 114
male (114) 114
heart failure (92) 92
middle aged (92) 92
aged (88) 88
adult (50) 50
mortality (48) 48
heart failure - physiopathology (47) 47
prognosis (47) 47
treatment outcome (47) 47
chemistry (43) 43
human necessities (43) 43
metallurgy (43) 43
hygiene (39) 39
medical or veterinary science (39) 39
follow-up studies (37) 37
risk factors (34) 34
surgery (32) 32
diagnosis (31) 31
heart failure - mortality (31) 31
biochemistry (29) 29
heart failure - drug therapy (29) 29
animals (28) 28
beer (28) 28
enzymology (28) 28
microbiology (28) 28
mutation or genetic engineering (28) 28
spirits (28) 28
vinegar (28) 28
wine (28) 28
compositions thereof (27) 27
culture media (27) 27
microorganisms or enzymes (27) 27
propagating, preserving or maintaining microorganisms (27) 27
cardiovascular (26) 26
aged, 80 and over (25) 25
analysis (25) 25
prospective studies (24) 24
abridged index medicus (23) 23
preparations for medical, dental, or toilet purposes (23) 23
retrospective studies (23) 23
stroke volume - physiology (23) 23
outcomes (22) 22
prevalence (22) 22
specific therapeutic activity of chemical compounds ormedicinal preparations (22) 22
echocardiography (21) 21
heart failure - diagnosis (21) 21
hospitalization (20) 20
stroke volume (20) 20
cardiac patients (18) 18
heart failure - therapy (18) 18
polysaccharides (18) 18
survival (18) 18
adolescent (17) 17
compositions based thereon (17) 17
organic macromolecular compounds (17) 17
their preparation or chemical working-up (17) 17
derivatives thereof (16) 16
guidelines (16) 16
heart failure - epidemiology (16) 16
care and treatment (15) 15
association (14) 14
cells, cultured (14) 14
epidemiology (14) 14
life sciences (14) 14
management (14) 14
therapy (14) 14
acute disease (13) 13
chronic disease (13) 13
disease (13) 13
drug therapy (13) 13
health aspects (13) 13
incidence (13) 13
mice (13) 13
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (12) 12
disinfection, sterilisation, or deodorisation of air (12) 12
heart (12) 12
heart-failure (12) 12
italy - epidemiology (12) 12
materials for bandages, dressings, absorbent pads, or surgicalarticles (12) 12
methods or apparatus for sterilising materials or objects ingeneral (12) 12
morbidity (12) 12
population (12) 12
preserved ejection fraction (12) 12
risk (12) 12
double-blind (11) 11
double-blind method (11) 11
enalapril (11) 11
impact (11) 11
medicine, general & internal (11) 11
myocardial-infarction (11) 11
patients (11) 11
peripheral vascular disease (11) 11
respiratory system (11) 11
ventricular function, left (11) 11
angiotensin-converting enzyme inhibitors - therapeutic use (10) 10
biomarkers - blood (10) 10
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (433) 433
French (49) 49
Spanish (27) 27
Italian (12) 12
German (5) 5
Finnish (3) 3
Portuguese (2) 2
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 19, pp. 2059 - 2071
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article